Tabula Rasa HealthCare Inc (NASDAQ:TRHC) Director Glen R. Bressner bought 8,500 shares of Tabula Rasa HealthCare stock in a transaction on Tuesday, October 4th. The stock was acquired at an average price of $12.00 per share, for a total transaction of $102,000.00. Following the transaction, the director now directly owns 2,793,932 shares of the company’s stock, valued at $33,527,184. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) opened at 13.45 on Thursday. Tabula Rasa HealthCare Inc has a 52 week low of $13.16 and a 52 week high of $16.17. The stock has a 50 day moving average price of $14.42 and a 200-day moving average price of $14.42.

About Tabula Rasa HealthCare

Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.

5 Day Chart for NASDAQ:TRHC

Receive News & Stock Ratings for Tabula Rasa HealthCare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare Inc and related stocks with our FREE daily email newsletter.